SCHEMBL20877620

SCHEMBL20877620

C=CC([C@H](O)C=C)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 2/20 0.41
▸ LMNA P02545 1/20 0.40
▸ ALDH1A1 P00352 9/20 0.40
▸ GAA P10253 1/20 0.39
▸ POLB P06746 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ APEX1 P27695 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20877618 1.00 CASP3 (0.41) CASP3LMNAALDH1A1GAAPOLB
SCHEMBL20877661 0.82 CES1 (0.41) CASP3ALDH1A1GAANPSR1
SCHEMBL20877660 0.82 CES1 (0.41) CASP3ALDH1A1GAANPSR1
SCHEMBL13937944 0.80 TDP1 (0.46) CASP3LMNAALDH1A1GAAPOLB
SCHEMBL13937923 0.80 TDP1 (0.46) CASP3LMNAALDH1A1GAAPOLB
SCHEMBL9064462 0.79 TDP1 (0.49) CASP3LMNAALDH1A1GAAPOLB
SCHEMBL14015874 0.76 TDP1 (0.40) CASP3LMNAALDH1A1GAAPOLB
SCHEMBL12134381 0.75 TDP1 (0.45) CASP3LMNAALDH1A1GAATP53
SCHEMBL10658500 0.74 TNF (0.40) CASP3LMNAALDH1A1GAAPOLB
SCHEMBL10590544 0.74 LMNA (0.46) CASP3LMNAALDH1A1GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752625-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds SCIFLUOR LIFE SCIENCES, INC. (US) 2020-08-25 — — US disclosed
US-20190194195-A1 METHOD OF MAKING TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID COMPOUNDS FELIQS CORPORATION (JP) 2019-06-27 — — US disclosed
US-10253025-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds SCIFLUOR LIFE SCIENCES, INC. (US) 2019-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194195-A1 METHOD OF MAKING TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID COMPOUNDS NISCH, SLC10A1, AANAT CASP3 3177/4885LMNA 2521/4885ALDH1A1 700/4885
US-10752625-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds NISCH, SLC10A1, AANAT CASP3 3177/4885LMNA 2521/4885ALDH1A1 700/4885
US-10253025-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds NISCH, SLC10A1, AANAT CASP3 3177/4885LMNA 2521/4885ALDH1A1 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback